These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 207416

  • 21. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A.
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [Abstract] [Full Text] [Related]

  • 22. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE, Selner M, Phillips JR.
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [Abstract] [Full Text] [Related]

  • 23. Adenosine receptors and modulation of natural killer cell activity by purine nucleosides.
    Priebe T, Platsoucas CD, Nelson JA.
    Cancer Res; 1990 Jul 15; 50(14):4328-31. PubMed ID: 1694721
    [Abstract] [Full Text] [Related]

  • 24. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
    Plunkett W, Alexander L, Chubb S, Loo TL.
    Cancer Res; 1979 Sep 15; 39(9):3655-60. PubMed ID: 476690
    [No Abstract] [Full Text] [Related]

  • 25. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul 15; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 26. Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin.
    Agarwal RP, Blatt J, Miser J, Sallan S, Lipton JM, Reaman GH, Holcenberg J, Poplack DG.
    Cancer Res; 1982 Sep 15; 42(9):3884-6. PubMed ID: 6980706
    [Abstract] [Full Text] [Related]

  • 27. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG, Jones BR.
    J Gen Virol; 1977 Jul 15; 36(1):199-202. PubMed ID: 196039
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
    Williams BB, Lerner AM.
    J Infect Dis; 1975 Jun 15; 131(6):673-7. PubMed ID: 166117
    [Abstract] [Full Text] [Related]

  • 31. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Juranka P, Chan VL.
    Cancer Res; 1980 Nov 15; 40(11):4123-6. PubMed ID: 6162544
    [Abstract] [Full Text] [Related]

  • 32. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
    Müller WE, Maidhof A, Zahn RK, Shannon WM.
    Cancer Res; 1977 Jul 15; 37(7 Pt 1):2282-90. PubMed ID: 301056
    [No Abstract] [Full Text] [Related]

  • 33. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.
    Müller WE, Rohde HJ, Beyer R, Maidhof A, Lachmann M, Taschner H, Kahn RK.
    Cancer Res; 1975 Aug 15; 35(8):2160-8. PubMed ID: 1149031
    [Abstract] [Full Text] [Related]

  • 34. Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis.
    Kaufman HE, Varnell ED.
    Antimicrob Agents Chemother; 1976 Dec 15; 10(6):885-8. PubMed ID: 1008546
    [Abstract] [Full Text] [Related]

  • 35. [Action of deoxyadenosine on nucleic acid synthesis by tumor cells in the presence of a deaminase inhibitor].
    Vornovitskaia GI, Ioannesiants IA, Borzenko BG, Shapot VS.
    Vopr Med Khim; 1975 Dec 15; 21(2):192-5. PubMed ID: 166514
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS, Yu J, Yu AL.
    J Immunol; 1983 Dec 15; 131(6):2762-6. PubMed ID: 6196398
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 15; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
    North TW.
    Cancer Res; 1984 Apr 15; 44(4):1415-9. PubMed ID: 6322976
    [Abstract] [Full Text] [Related]

  • 40. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse.
    Knudsen TB, Winters RS, Otey SK, Blackburn MR, Airhart MJ, Church JK, Skalko RG.
    Teratology; 1992 Jan 15; 45(1):91-103. PubMed ID: 1731400
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.